Semaglutide 2.4 mg
Semaglutide produced much greater percentage body weight loss than placebo at 68 weeks. Most semaglutide participants achieved clinically meaningful categorical weight-loss thresholds. Semaglutide produced greater absolute body weight redu…
1 sources - 5 claims
Semaglutide produced much greater percentage body weight loss than placebo at 68 weeks. Most semaglutide participants achieved clinically meaningful categorical weight-loss thresholds. Semaglutide produced greater absolute body weight reduction than placebo. All semaglutide participants who completed the trial reached the 2.4 mg target dose. BARI-STEP tested semaglutide 2.4 mg once weekly plus lifestyle intervention in adults with poor weight loss after gastric bypass or sleeve gastrectomy.